Second-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment:an Open-label, Randomized, Controlled Phase II Clinical Study

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Intrahepatic Cholangiocarcinoma (Icc)
Interventions
RADIATION

radiotherapy

Radiotherapy

DRUG

FOLFIRI or FOLFOX or Regorafenib

FOLFIRI or FOLFOX or Regorafenib

Trial Locations (1)

200032

Zhongshan Hospital, Fudan University, Shanghai

All Listed Sponsors
lead

Shanghai Zhongshan Hospital

OTHER